Screening Programmes definition

Screening Programmes means co-ordinated NHS activity that aims to identify early indications or particular conditions in Service Users;
Sample 1Sample 2Sample 3
Screening Programmes means co-ordinated national and/or local NHS activity that aims to identify early indications of particular conditions in patients; “Secretary of State” means the Secretary of State for Health;
Sample 1
Screening Programmes means co-ordinated NHS activity that aims to identify early
Sample 1

Examples of Screening Programmes in a sentence

  • Newborn hearing screening and assessment: Guidance for auditory brainstem response testing in babies, v2.1. NHS Antenatal Newborn Hearing Screening Programmes.

  • IARC Working Group on Evaluation of Cervical Cancer Screening Programmes.

  • One of the objectives of the NHS Screening Programmes is to help reduce health inequalities.

  • Working Group on the Registration and Monitoring of Cervical Cancer Screening Programmes in the European Union; within the European Network for Information on Cancer (EUNICE).

  • Breast Cancer Screening Programmes: The Development of a Monitoring and Evaluation System.

  • Outline the benefits and challenges for the National Cancer Screening Programmes regarding implementation of the proposed systems of audit of interval cancer.

  • Some ‘Issues to be Addressed’ are not inequalities, e.g. in the PHA action plan, “Cancer Screening Programmes: Commissioning and quality assuring cancer screening programmes” is a function.

  • The search for silent witnesses: Women’s experiences of red cell antibodies in pregnancyDonna Kirwan, Regional Coordinator Antenatal Screening Programmes, Department of Public Health, Central Liverpool Primary Care Trust, Liverpool, United KingdomAbstract:Background:Information about the biological and scientific aspect of red cell antibodies in pregnancy is plentiful within current literature.

  • These Funding Guidelines for Ear and Hearing Health Screening Programmes (the Guidelines) result from that process.

  • Eliciting Preferences for Information Provision in Newborn Bloodspot Screening Programmes.

Related to Screening Programmes

  • Training program means a standardized medication

  • Screening means the evaluation process used to identify an individual's ability to perform activities of daily living and address health and safety concerns.

  • Learning Programme means a programme of education and/or training delivered by the Provider under this Agreement;

  • Programme means any television broadcast and includes-

  • Study means the investigation to be conducted in accordance with the Protocol.

  • the Programme means the Government programme for delivery of smart metering in Great Britain. The Programme is responsible for overseeing the development and implementation of policy, including establishing the commercial and regulatory framework to facilitate the roll-out;

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Prescription monitoring program means the electronic system within the Department of Health Professions that monitors the dispensing of certain controlled substances.

  • Marketing program means a program established by order of the director pursuant to this act prescribing rules and regulations governing the marketing for processing, distributing, selling, or handling an agricultural commodity produced in this state or agricultural commodity input during a specified period and

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • Development Program means the implementation of the development plan.

  • Step therapy protocol means a protocol or program that establishes the specific

  • Assay means a laboratory analysis of Crude Petroleum to include the following: A.P.I. Gravity, Reid vapor pressure, composition, pour point, water and sediment content, sulfur content, viscosity, distillation, hydrogen sulfide, flash/boiling point and other characteristics as may be required by Carrier.

  • Research-based means a program or practice that has some research demonstrating effectiveness, but that does not yet meet the standard of evidence-based practices.

  • Licensed Programs means, collectively, NeoSystems’ and any Third Party Vendor computer software programs to be provided to Client for use on certain hardware on Client’s premises or a third party’s premises as set forth in an Agreement. The Licensed Programs shall include any fixes, work-arounds, updates, revisions, modifications, enhancements and any derivative works that are provided to Client by NeoSystems under an Agreement.

  • Research Program has the meaning set forth in Section 2.1.

  • Development Work means the conduct of preclinical and clinical trials, the compilation of the regulatory dossier concerning Licensed Products and the conduct of other work necessary or useful for obtaining Regulatory Approval of Licensed Products.

  • Clinical Studies means Xxxxx 0, Xxxxx 0, Xxxxx 0, Xxxxx 3, and such other tests and studies in human subjects that are required by Applicable Law, or otherwise recommended by the Regulatory Authorities, to obtain or maintain Regulatory Approvals for a Licensed Product for one (1) or more indications, including tests or studies that are intended to expand the Product Labeling for such Licensed Product with respect to such indication.

  • Protocol means, in respect of any category of object and associated rights to which this Convention applies, the Protocol in respect of that category of object and associated rights;

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Monitoring Indicator means a measure of HSP performance that may be monitored against provincial results or provincial targets, but for which no Performance Target is set;

  • QA means quality assurance.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Protocols means written directions and orders, consistent with the department’s standard of care, that are to be followed by an emergency medical care provider in emergency and nonemergency situations. Protocols must be approved by the service program’s medical director and address the care of both adult and pediatric patients.

  • Licensed Program means the executable processing programs of licensed information, which is composed of various modules in the Licensed Software package provided by the Licensor.

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.